Overview

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the influence of posaconazole on unboosted fosamprenavir pharmacokinetics, and vice versa, in healthy volunteers.A second objective is to determine the safety of combined use of fosamprenavir with posaconazole in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Collaborator:
GlaxoSmithKline
Treatments:
Fosamprenavir
Posaconazole
Ritonavir